![]() |
市場調查報告書
商品編碼
1775380
醫療包裝薄膜市場:未來預測(2025-2030)Medical Packaging Films Market - Forecasts from 2025 to 2030 |
預計醫療包裝薄膜市場規模將從 2025 年的 85.44 億美元成長到 2030 年的 117.63 億美元,複合年成長率為 6.60%。
由於對生物技術注射藥物的需求不斷成長以及醫療和製藥行業的不斷擴張,醫用包裝薄膜市場正在經歷強勁成長。這些藥物通常對熱敏感,需要能夠確保產品保護、品質、防篡改和患者安全的包裝解決方案,而無需依賴高溫末端穩定製程。醫用包裝薄膜在滿足這些需求並為藥品包裝提供可靠且高效的解決方案方面發揮關鍵作用。
市場促進因素
政府對先進醫療系統的投資是醫用包裝薄膜市場的主要驅動力。例如,在韓國,超過一半的醫療支出由國家和州政府資助,國民健康保險 (NHI) 涵蓋約 96% 的人口,佔醫療總支出的近一半。這提高了醫療服務的可用性和可近性,刺激了對醫療包裝解決方案的需求。同樣,在澳大利亞,醫療保健支出預計將在 2024 年達到 1,810 億美元,年增 6%,其中超過三分之二由聯邦和州政府資助。醫療保險福利計劃 (MBS) 和藥品福利計劃 (PBS) 等項目津貼基層醫療並吸引私人投資於醫療設備和包裝。預計這些政策將透過鼓勵創新和採用先進的包裝解決方案來推動未來五年的市場成長。
市場區隔
聚丙烯 (PP) 憑藉其環保特性和優異的防潮性能,在醫藥包裝行業中獲得了廣泛認可,佔據了相當大的市場佔有率。在歐洲等法律限制焚燒聚氯乙烯( PVC) 的地區,PP 正逐漸取代聚氯乙烯 (PVC)。 PP 適用於泡殼包裝,其強大的防潮性能也促使其在醫藥應用領域廣泛採用。例如,主要企業(SIBUR) 推出了一種基於 PP 的新型包裝解決方案,該解決方案採用了專為醫藥行業泡殼包裝量身定做的 Millad NX 8000。預計對 PP 的持續投資將進一步提升其在市場上的主導地位。
區域成長:亞太地區領先
亞太地區是醫療包裝薄膜市場的主要成長引擎,這得益於不斷提升的健康意識以及公共和私營部門的大量投資。該地區擁有一些全球最大的醫藥包裝公司,並受益於豐富的原料和低廉的生產成本。
本報告的主要優點
它有什麼用途?
產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響
The Medical Packaging Films Market is expected to grow from USD 8.544 billion in 2025 to USD 11.763 billion in 2030, at a CAGR of 6.60%.
The medical packaging films market is experiencing robust growth, driven by the increasing demand for biotechnology-based injectable drugs and expanding healthcare and pharmaceutical sectors. These drugs, often heat-sensitive, require packaging solutions that ensure product protection, quality, tamper-evidence, and patient safety without relying on high-heat terminal stabilization processes. Medical packaging films are critical in meeting these needs, offering reliable and efficient solutions for pharmaceutical packaging.
Market Growth Drivers
Government investments in advanced healthcare systems are a key driver of the medical packaging films market. In South Korea, for instance, over half of healthcare spending is funded by national and state governments, with the National Healthcare Insurance (NHI) covering approximately 96% of the population and nearly half of total healthcare costs. This enhances affordability and access to healthcare services, spurring demand for medical packaging solutions. Similarly, in Australia, healthcare spending reached $181 billion in 2024, a 6% increase from the previous year, with over two-thirds funded by federal and state governments. Programs like the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS) subsidize primary care and ensure affordability, attracting private investment in medical equipment and packaging. These policies are expected to drive market growth over the next five years by fostering innovation and adoption of advanced packaging solutions.
Market Segment Analysis
Polypropylene (PP) is gaining significant traction in the pharmaceutical packaging industry, holding a substantial market share due to its eco-friendly properties and excellent moisture-barrier capabilities. It is increasingly replacing polyvinyl chloride (PVC) in regions like Europe, where legislation restricts PVC incineration. PP's suitability for blister packaging, which provides robust moisture protection, has fueled its adoption in pharmaceutical applications. For example, SIBUR, a leading Russian company, introduced new PP-based packaging solutions incorporating Millad NX 8000, tailored for blister packaging in the pharmaceutical sector. Continued investments in PP are expected to further bolster its dominance in the market.
Regional Growth: Asia Pacific Leading the Way
The Asia Pacific region is a major growth engine for the medical packaging films market, driven by rising health awareness and significant investments from both public and private sectors. The region hosts some of the world's largest pharmaceutical packaging companies, benefiting from abundant raw materials and low production costs.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Key Market Segmentation: